Targeting mutant p53 for cancer therapy: direct and indirect strategies

J Hu, J Cao, W Topatana, S Juengpanich, S Li… - Journal of hematology & …, 2021 - Springer
TP53 is a critical tumor-suppressor gene that is mutated in more than half of all human
cancers. Mutations in TP53 not only impair its antitumor activity, but also confer mutant p53 …

[HTML][HTML] Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting

LJH Borrero, WS El-Deiry - Biochimica et Biophysica Acta (BBA)-Reviews …, 2021 - Elsevier
TP53 is the most commonly mutated gene in human cancer with over 100,000 literature
citations in PubMed. This is a heavily studied pathway in cancer biology and oncology with a …

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

X Chen, T Zhang, W Su, Z Dou, D Zhao, X Jin… - Cell Death & …, 2022 - nature.com
TP53, a crucial tumor suppressor gene, is the most commonly mutated gene in human
cancers. Aside from losing its tumor suppressor function, mutant p53 (mutp53) often …

Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy

MJ Ramaiah, AD Tangutur, RR Manyam - Life sciences, 2021 - Elsevier
The role of genetic and epigenetic factors in tumor initiation and progression is well
documented. Histone deacetylases (HDACs), histone methyl transferases (HMTs), and DNA …

Mutant p53 as a guardian of the cancer cell

F Mantovani, L Collavin, G Del Sal - Cell Death & Differentiation, 2019 - nature.com
Forty years of research have established that the p53 tumor suppressor provides a major
barrier to neoplastic transformation and tumor progression by its unique ability to act as an …

The roles of histone deacetylases and their inhibitors in cancer therapy

G Li, Y Tian, WG Zhu - Frontiers in cell and developmental biology, 2020 - frontiersin.org
Genetic mutations and abnormal gene regulation are key mechanisms underlying
tumorigenesis. Nucleosomes, which consist of DNA wrapped around histone cores …

The role of p53 signaling in colorectal cancer

MC Liebl, TG Hofmann - Cancers, 2021 - mdpi.com
Simple Summary The transcription factor p53 is a crucial tumor suppressor that regulates
diverse cellular responses to protect against cancer development. Deactivating p53 …

Gain-of-function mutant p53 in cancer progression and therapy

C Zhang, J Liu, D Xu, T Zhang, W Hu… - Journal of molecular …, 2020 - academic.oup.com
Abstract p53 is a key tumor suppressor, and loss of p53 function is frequently a prerequisite
for cancer development. The p53 gene is the most frequently mutated gene in human …

Mutant p53 in cancer progression and targeted therapies

G Zhu, C Pan, JX Bei, B Li, C Liang, Y Xu, X Fu - Frontiers in oncology, 2020 - frontiersin.org
TP53 is the most frequently mutated tumor suppressor gene in human cancer. The majority
of mutations of p53 are missense mutations, leading to the expression of the full length p53 …

Targeting apoptotic pathways for cancer therapy

X Tian, PR Srinivasan, V Tajiknia… - The Journal of clinical …, 2024 - jci.org
Apoptosis is a form of programmed cell death that is mediated by intrinsic and extrinsic
pathways. Dysregulation of and resistance to cell death are hallmarks of cancer. For over …